Table 2.
Canonical pathways | P-value | Number of differentially expressed molecules to total in pathway |
---|---|---|
Natural Killer Cell Signaling | 1.6 × 10-7 | 20/115 (17.4%) |
NF-kB Signaling | 8.9 × 10-5 | 17/149 (11.4%) |
Cytotoxic T Lymphocyte-mediated Apoptosis of Target Cells | 3.7 × 10-4 | 7/31 (22.6%) |
T Cell Receptor Signaling | 9.9 × 10-4 | 13/110 (11.8%) |
Communication between Innate and Adaptive Immune Cells | 1.6 × 10-3 | 10/90 (11.1%) |
| ||
Biological functions | P-value | Number of differentially expressed molecules |
| ||
Inflammatory Response | ≤ 5.8 × 10-3 | 132 |
Infectious Disease | ≤ 8.0 × 10-3 | 100 |
Respiratory Disease | ≤ 8.0 × 10-3 | 74 |
Inflammatory Disease | ≤ 7.3 × 10-3 | 193 |
Immunological Disease | ≤ 8.0 × 10-3 | 187 |
Antigen Presentation | ≤ 6.6 × 10-3 | 125 |
Cell-To-Cell Signaling and Interaction | ≤ 8.0 × 10-3 | 140 |
Cell-mediated Immune Response | ≤ 8.0 × 10-3 | 139 |
Humoral Immune Response | ≤ 5.4 × 10-3 | 122 |
Hematological System Development and Function | ≤ 5.4 × 10-3 | 134 |
Immune Cell Trafficking | .≤ 7.4 × 10-3 | 88 |